Core Scientific, Inc. (NASDAQ:CORZ) Shares Bought by Deuterium Capital Management LLC

Deuterium Capital Management LLC increased its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 58.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 190,723 shares of the company's stock after acquiring an additional 70,723 shares during the period. Core Scientific accounts for about 7.1% of Deuterium Capital Management LLC's holdings, making the stock its 5th largest position. Deuterium Capital Management LLC owned about 0.07% of Core Scientific worth $2,717,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in CORZ. Creative Planning increased its holdings in shares of Core Scientific by 88.0% during the 3rd quarter. Creative Planning now owns 32,925 shares of the company's stock valued at $389,000 after acquiring an additional 15,413 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Core Scientific by 96.2% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 78,077 shares of the company's stock valued at $926,000 after buying an additional 38,292 shares during the last quarter. Van ECK Associates Corp grew its holdings in Core Scientific by 22.9% in the 3rd quarter. Van ECK Associates Corp now owns 1,616,944 shares of the company's stock valued at $19,177,000 after buying an additional 300,942 shares during the last quarter. Harvest Portfolios Group Inc. grew its holdings in Core Scientific by 10.1% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 55,881 shares of the company's stock valued at $663,000 after buying an additional 5,109 shares during the last quarter. Finally, CWA Asset Management Group LLC acquired a new stake in Core Scientific in the 3rd quarter valued at approximately $890,000.

Remove Ads

Core Scientific Price Performance

Shares of Core Scientific stock traded down $0.07 during midday trading on Friday, hitting $7.78. 31,827,030 shares of the company were exchanged, compared to its average volume of 10,516,301. The firm has a market cap of $2.29 billion, a P/E ratio of -1.44 and a beta of 6.83. Core Scientific, Inc. has a 52 week low of $2.61 and a 52 week high of $18.63. The firm has a 50 day simple moving average of $12.65 and a 200-day simple moving average of $13.26.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to the consensus estimate of $97.07 million. Equities research analysts expect that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Insider Buying and Selling

In other Core Scientific news, CEO Adam Taylor Sullivan sold 369,712 shares of Core Scientific stock in a transaction on Friday, January 24th. The stock was sold at an average price of $16.24, for a total value of $6,004,122.88. Following the completion of the transaction, the chief executive officer now owns 3,758,793 shares in the company, valued at approximately $61,042,798.32. The trade was a 8.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Todd M. Duchene sold 129,861 shares of Core Scientific stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total value of $1,849,220.64. Following the completion of the transaction, the insider now owns 2,051,649 shares of the company's stock, valued at approximately $29,215,481.76. The trade was a 5.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 748,282 shares of company stock worth $10,978,104 in the last 90 days. 32.00% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have issued reports on CORZ. Macquarie raised their target price on Core Scientific from $16.00 to $19.00 and gave the company an "outperform" rating in a report on Thursday, November 14th. Keefe, Bruyette & Woods began coverage on Core Scientific in a report on Monday, January 27th. They issued an "outperform" rating and a $22.00 target price on the stock. Needham & Company LLC lowered their target price on Core Scientific from $18.00 to $17.00 and set a "buy" rating on the stock in a report on Thursday, February 27th. Compass Point lowered their target price on Core Scientific from $26.00 to $20.00 and set a "buy" rating on the stock in a report on Tuesday, February 25th. Finally, Roth Capital raised Core Scientific to a "strong-buy" rating in a report on Thursday, November 14th. Fifteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $19.07.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.